Pinz Capital Management, LP Intellia Therapeutics, Inc. Transaction History

Pinz Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$132.37 - $176.78 $119,133 - $159,102	-900 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$60.88 - $161.91 $54,792 - $145,719	900 New	900 $146,000
Q1 2021 May 17, 2021	SELL	$46.59 - $83.68 $2.05 Million - $3.68 Million	-44,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$18.83 - $63.53 $828,519 - $2.8 Million	44,000 New	44,000 $2.39 Million
Q3 2020 Nov 16, 2020	SELL	$17.47 - $24.93 $1.08 Million - $1.54 Million	-61,950 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$11.14 - $22.87 $690,123 - $1.42 Million	61,950 New	61,950 $1.3 Million

333

95.3M

1.06M

863K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $550M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Pinz Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Pinz Capital Management, LP with notifications on news.